Post-transplant Cytomegalovirus (CMV) Infection
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB06234 | Maribavir | A cytomegalovirus (CMV) pUL97 kinase inhibitor used for the treatment of refractory post-transplant CMV infection. |
| Drug | Drug Name | Target | Type |
|---|---|---|---|
| DB06234 | Maribavir | Serine/threonine protein kinase UL97 | target |
| DB06234 | Maribavir | Cytochrome P450 3A4 | enzyme |
| DB06234 | Maribavir | Cytochrome P450 1A2 | enzyme |
| DB06234 | Maribavir | Serum albumin | carrier |
| DB06234 | Maribavir | Alpha-1-acid glycoprotein 1 | carrier |
| DB06234 | Maribavir | ATP-binding cassette sub-family G member 2 | transporter |
| DB06234 | Maribavir | P-glycoprotein 1 | transporter |
| Drug | Drug Name | Phase | Status | Count |
|---|